Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | UCB6114 |
| Trade Name | |
| Synonyms | UCB 6114|UCB-6114|Ginisortamab |
| Drug Descriptions |
UCB6114 is a monoclonal antibody that binds to Gremlin-1, resulting in activation of BMP and potentially leading to anti-tumor activity (Journal of Clinical Oncology 2022 40:4_suppl, TPS221). |
| DrugClasses | |
| CAS Registry Number | 2390147-17-6 |
| NCIT ID | C173701 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Fluorouracil + Leucovorin + Oxaliplatin + UCB6114 | Fluorouracil Leucovorin Oxaliplatin UCB6114 | 0 | 1 |
| Trifluridine-tipiracil hydrochloride + UCB6114 | Trifluridine-tipiracil hydrochloride UCB6114 | 0 | 1 |
| UCB6114 | UCB6114 | 0 | 1 |